AU2002300904A1 - Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia - Google Patents

Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia

Info

Publication number
AU2002300904A1
AU2002300904A1 AU2002300904A AU2002300904A AU2002300904A1 AU 2002300904 A1 AU2002300904 A1 AU 2002300904A1 AU 2002300904 A AU2002300904 A AU 2002300904A AU 2002300904 A AU2002300904 A AU 2002300904A AU 2002300904 A1 AU2002300904 A1 AU 2002300904A1
Authority
AU
Australia
Prior art keywords
treatment
benign prostatic
prostatic hyperplasia
piperazines useful
arylsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002300904A
Other versions
AU2002300904B2 (en
Inventor
Linda Jolliffe
Xiaobing Li
Cynthia Maryanoff
Linda Mulcahy
William Murray
Virginia Pulito
Allen B. Reitz
Frank Villani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU73669/98A external-priority patent/AU7366998A/en
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Priority to AU2002300904A priority Critical patent/AU2002300904B2/en
Priority claimed from AU2002300904A external-priority patent/AU2002300904B2/en
Publication of AU2002300904A1 publication Critical patent/AU2002300904A1/en
Application granted granted Critical
Publication of AU2002300904B2 publication Critical patent/AU2002300904B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002300904A 1997-05-12 2002-09-06 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia Ceased AU2002300904B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002300904A AU2002300904B2 (en) 1997-05-12 2002-09-06 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60046236 1997-05-12
AU73669/98A AU7366998A (en) 1997-05-12 1998-05-08 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
AU2002300904A AU2002300904B2 (en) 1997-05-12 2002-09-06 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU73669/98A Division AU7366998A (en) 1997-05-12 1998-05-08 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia

Publications (2)

Publication Number Publication Date
AU2002300904A1 true AU2002300904A1 (en) 2003-02-20
AU2002300904B2 AU2002300904B2 (en) 2004-12-23

Family

ID=39263010

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002300904A Ceased AU2002300904B2 (en) 1997-05-12 2002-09-06 Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia

Country Status (1)

Country Link
AU (1) AU2002300904B2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0558245A1 (en) * 1992-02-25 1993-09-01 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Heterobicyclic compounds as antagogists of alpha-1 adrenergic and SHT1A receptors
IT1266582B1 (en) * 1993-07-30 1997-01-09 Recordati Chem Pharm (DI) AZACYLO-HEXANIC AND DIAZACYLO-HEPTANIC DERIVATIVES

Similar Documents

Publication Publication Date Title
SI0968208T1 (en) Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
AU5173296A (en) Prostatic tissue expander
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU1316000A (en) Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
AP9901684A0 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
AU1657097A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
EP0855910A4 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
AU2418499A (en) Org-5222 in the treatment of depression
HK1030776A1 (en) Substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia
AU2160697A (en) Nsaids in the treatment of pruritus
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
AU2002300904A1 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
AU6570998A (en) Prostate specific antigen from benign prostatic hyperplasia and its use in diagnosis
ZA991319B (en) Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
AU8053798A (en) Tissue plasminogen activator-like protease
AU5457694A (en) Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
GB9602903D0 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
EP0748627A3 (en) Melatonin agonists for use in the treatment of benign prostatic hyperplasia
EP1140906A4 (en) Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
AU2003204320A1 (en) Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
AU2713797A (en) Depigmentating agent in the treatment of melasma
GB9810895D0 (en) Combination therapy for the treatment of benign prostatic hyperplasia
SI0925069T1 (en) Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer
AU5408099A (en) Electrically treated composition and use thereof
AU681995B3 (en) Fragrance burner body and fragrance burner